This content is machine translated News from dermatooncology Melanoma with or without BRAF mutation – new therapies in the pipeline Data from two phase III trials (both from the research group led by Caroline Robert, MD, Institut Gustave Roussy in Villejuif, Paris) published earlier this year highlight the rapid development…
View Post 5 min This content is machine translated Early detection begins in the family doctor's office Melanocytic nevi and malignant melanoma Melanocytic nevi are the most common benign neoplasms in fair skin types. Their number is a risk indicator for the development of malignant melanoma, of which they may be precursors.…
